Skip to content

Correlation analysis between SARS-CoV-2 vaccination and idiopathic facial paralysis: a case-control study

Correlation analysis between SARS-CoV-2 vaccination and idiopathic facial paralysis: a case-control study

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2400090580
Enrollment
Unknown
Registered
2024-10-09
Start date
2024-10-14
Completion date
Unknown
Last updated
2024-10-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Idiopathic facial paralysis

Interventions

Case group:NA
control group:NA

Sponsors

Shanghai General Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1. Age is 18 years old and above 2. Patients diagnosed with idiopathic facial nerve paralysis (facial neuritis, peripheral facial nerve paralysis) at the outpatient department of Shanghai First People's Hospital 3. The initial visit date is from February 1, 2021 to January 31, 2022 4. Diagnosed and treated by a neurology specialist or emergency department physician, based on clinical manifestations consistent with idiopathic facial nerve paralysis

Exclusion criteria

Exclusion criteria: 1. History of idiopathic facial nerve paralysis in the past 2. Suffering from other diseases that cause facial nerve paralysis, including cerebrovascular disease, demyelinating diseases, tumors, central nervous system infections, trauma, otitis media, mastoiditis, Melkersson Rosenthal syndrome, etc 3. Missing vaccination information and incomplete baseline data

Design outcomes

Primary

MeasureTime frame
The onset of idiopathic facial nerve paralysis;

Countries

China

Contacts

Public ContactQiaoshu Wang

Shanghai General Hospital

qwang624@139.com+86 133 1000 1181

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026